The effect of raloxifene supplementation on blood pressure and Apo-lipoproteins in postmenopausal women: A systematic review and meta-analysis
- 27 September 2024
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 175, 106912
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences (75042)
This publication has 36 references indexed in Scilit:
- Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studiesEndocrine, 2022
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without AtherosclerosisJAMA Cardiology, 2021
- The Effect of Raloxifene Treatment on Lipid Profile in Elderly Individuals: A Systematic Review and Meta-analysis of Randomized Clinical TrialsClinical Therapeutics, 2021
- HDL cholesterol and apolipoprotein A-I concentrations and risk of atherosclerotic cardiovascular disease: Human genetics to unravel causalityAtherosclerosis, 2020
- Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled TrialsCardiovascular Drugs and Therapy, 2017
- Random-effects model for meta-analysis of clinical trials: An updateContemporary Clinical Trials, 2007
- Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal womenJournal of Endocrinological Investigation, 2005
- Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal womenInternational Journal of Gynecology & Obstetrics, 2005
- Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal WomenJAMA, 2002
- Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal WomenJAMA, 1998